Monitor the company's next earnings call for any commentary on the strategic direction from the newly expanded board, particularly regarding the Return-to-Growth action plan. The addition of financial experts to key committees may signal a focus on capital allocation and financial discipline.
How the stock moved after the report
NEUTRAL VIEWSTOCK BELOW ENTRY AT T+60- T+0 · Feb 25 $12.80entry
- T+1 · 9mo ago −0.70%α −0.16% · $12.71
- T+5 · 9mo ago +5.00%α +6.10% · $13.44
- T+20 · 8mo ago −8.75%α −3.51% · $11.68
- T+60 · 6mo ago −23.13%α −30.08% · $9.84
Price Chart
REPLAYWatch the reaction play outHow similar events traded
Executive Summary
DENTSPLY SIRONA Inc. announced the appointment of James Forbes and Brian McKeon to its Board of Directors, effective February 27, 2026, as part of its ongoing board refreshment process. This follows the recent appointment of Don Zurbay and the retirement announcement of Willie Deese. The new directors bring extensive financial leadership and board experience to support the company's Return-to-Growth strategy.
Key Facts
- James D. Forbes and Brian P. McKeon appointed to the Board of Directors effective February 27, 2026
- Board size increased from 11 to 13 members
- Willie A. Deese notified the Board of his intent not to seek re-election at the 2026 annual meeting
- Forbes brings 30 years of healthcare investment banking experience, previously at Morgan Stanley
- McKeon brings 25 years of public company CFO experience, previously at IDEXX Laboratories
- Forbes will serve on the Compensation & Human Capital Committee
- McKeon will serve on the Audit and Finance Committee and Science and Technology Committee
Financial Impact
No direct financial impact reported
Risk Factors
- New board members may bring different strategic perspectives that could shift company direction
- Board refreshment process could continue with additional changes
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 5 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 8-K Filing (Primary) | 0000818479-26-000058 |
| Exhibit: ex991bodappointments_vff.htm | 0000818479-26-000058 |
| Document: 0000818479-26-000058-index-headers.html | 0000818479-26-000058 |
| Document: 0000818479-26-000058-index.html | 0000818479-26-000058 |
| Document: 0000818479-26-000058.txt | 0000818479-26-000058 |
Track record
15 reports on XRAY
The track record builds as more bullish or bearish reports settle.
Filters
- Nov 5, 202611d ago 8-K Bearish 6/10 No price data
- Nov 5, 202611d ago Press Release Bearish 6/10 Entry $9.46 to $9.16 Now $8.95 +5.39% ▲ +3.17% +5.77% vs SPY
- Nov 5, 202611d ago Institutional Cluster Neutral 2/10 Entry $10.09 to $9.24 Now $8.95 −11.30% ▼ −8.42% −11.71% vs SPY
- Oct 20, 202627d ago Press Release Neutral 1/10 Entry $9.08 Now $8.95 −1.43% No price data
- Oct 9, 20265w ago 8-K Neutral 4/10 Entry $8.53 to $8.42 Now $8.95 +4.92% ▼ −1.29% +0.20% vs SPY
- Sep 10, 20269w ago Institutional Cluster Mixed 5/10 Entry $10.50 to $9.38 Now $8.95 −14.76% ▼ −10.71% −10.22% vs SPY
- Jun 16, 202621w ago Insider Cluster Neutral 3/10 Entry $10.03 to $10.52 Now $8.95 −10.77% ▲ +4.89% +5.93% vs SPY
- Jun 15, 202622w ago Insider Cluster Neutral 3/10 Entry $10.45 to $10.20 Now $8.95 −14.35% ▼ −2.39% −0.16% vs SPY
- Jun 11, 202622w ago 8-K Neutral 3/10 Entry $10.14 to $10.03 Now $8.95 −11.74% ▼ −1.08% −1.52% vs SPY
- May 5, 202627w ago 8-K Bearish 6/10 No price data
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers